Page 305 - AIDSBK23C
P. 305

Page 305



               86      Young B, Kuritzkes DR. Viral kinetics: implications for treatment. AIDS. 1999;13(Suppl
                       1):S11-S17.

               87      Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and
                       consequences. J Pathol. 2008;214:231-241.

               88      Lehner T, Wang Y, Pido-Lopez J, Whittall T, Bergmeier LA, Babaahmady K. The
                       emerging role of innate immunity in protection against HIV-1 infection. Vaccine.
                       2008;26:2997-3001.

               89      Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, Johnson MC,
                       Bieniasz PD. Tetherin inhibitis HIV-1 release by directly tethering virions to cells. Cell.
                       2009;139:499-511.

               90      Furrer H, Wendland T, Minder C, et al. Association of syncytium-inducing phenotype of
                       HIV-1 with CD4 cell count, viral load, and sociodemographic characteristics. AIDS.
                       1998;12:1341-1346.

               91      Plantier JC, Damond F, Lasky M, et al. V3 serotyping of HIV-1 infection: correlation
                       with genotyping and limitations. J Acquir Immune Defic Syndr Hum Retrovirol.
                       1999;20:432-441.

               92      Knight SC, Patterson S. Bone marrow-derived dendritic cells, infection with human
                       immunodeficiency virus, and immunopathology. Annu Rev Immunol. 1997;15:593-615.

               93      Hu DJ, Buvé A,m Baggs J, van der Groen G, Dondero TJ. What role does HIV-1 subtype
                       play in transmission and pathogenesis? An epidemiologic perspective. AIDS.
                       1999;13:873-881.

               94      Neel C, Etienne L, Li Y, Takehisa J, Rudicell RS, Bass IN, Moudindo J, et al. Molecular
                       epidemiology of simian immunodeficiency virus infection in wild-living gorillas. J Virol.
                       2010;84:1464-1476.

               95      Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM. The challenge of HIV-1
                       subtype diversity. N Engl J Med. 2008;358:1590-1602.

               96      Jaffe HW, Schochetman G. Group O human immunodeficiency virus-1 infections. Infect
                       Dis Clin North Am. 1998;12:39-46.

               97      Simon F, Mauclere P, Roques P, et al. Identification of a new human immunodeficiency
                       virus type 1 distinct from group M and group O. Nat Med. 1998;4:1032-1037.

               98      Geretti AM. HIV-1 subtypes: epidemiology and significance for HIV management. Curr
                       Opin Infect Dis. 2006;19:1-7.
   300   301   302   303   304   305   306   307   308   309   310